T1	Condition 98 114	plaque psoriasis
T2	Condition-Name 98 114	plaque psoriasis
E1	Condition:T1 Name:T2 Severity:T12
T3	Life-Stage-And-Gender 25 33	Children
A1	Life-Stage-And-Gender-Type T3 child
T5	Temporal-Connection 121 126	Prior
E2	Temporal-Connection:T5 Arg:E7 Arg2:E8
T7	Eq-Comparison 506 511	prior
E3	Eq-Comparison:T7 Temporal-Period:T8
T8	Eq-Temporal-Period 506 511	prior
A3	Eq-Temporal-Period-Value T8 past
T9	Life-Stage-And-Gender 38 49	adolescents
A4	Life-Stage-And-Gender-Type T9 child
T10	Or 34 37	and
E4	Or:T10 Arg:T3 Arg2:T9
T11	Modifier 73 90	pediatric chronic
E5	Modifier:T11 Modifies:T2
T12	Severity 91 97	severe
A5	Severity-Value T12 severe
T13	And 50 53	who
E6	And:T13 Arg:T9 Arg2:E1
T14	Study 151 156	study
E7	Study:T14 
A2	Temporal-Connection-Type-Value E2 before
T6	Procedure 169 178	treatment
E8	Procedure:T6 
T15	Drug 158 168	adalimumab
E9	Drug:T15 Name:T16
T16	Drug-Name 158 168	adalimumab
R1	Using Arg1:E8 Arg2:E9	
T17	Drug 432 442	adalimumab
E10	Drug:T17 Name:T4
T4	Drug-Name 432 442	adalimumab
T18	Contraindication 412 428	contraindication
E11	Contraindication:T18 Contraindicates:E10
T19	Procedure 512 521	treatment
E12	Procedure:T19 Temporality:E3
T20	Drug 527 537	adalimumab
E13	Drug:T20 Name:T21
T21	Drug-Name 527 537	adalimumab
R2	Using Arg1:E12 Arg2:E13	
